NCT07341737 2026-01-15
SL-28 for Advanced Solid Tumours
Second Life Therapeutics
Phase 1/2 Not yet recruiting
Second Life Therapeutics
Ohio State University Comprehensive Cancer Center
Hangzhou DAC Biotechnology Co., Ltd.
Convalife (Shanghai) Co., Ltd.